Direct economic impact of Parkinson's disease: A research survey in the United Kingdom

The direct costs of care were evaluated prospectively in a sample of people with Parkinson's disease (PD) in the United Kingdom in 1998. The subjects were drawn from a random sample of general practitioner practices within a representative sample of 36 Regional Health Authorities and the equivalent. A total of 444 resource use questionnaires with usable data were returned (response rate, 59%). The total mean annual cost of care per patient for all patients by age was £5,993 (€9,554, n = 432). Hoehn and Yahr stage significantly (P < 0.001) influenced expenditure by stage as follows: 0 and I, £2,971 (€4,736, n = 110); II, £3,065 (€4,886, n = 89); III, £6,183 (€9,857, n = 120); IV, £10,134 (€16,155, n = 87); V, £18,358 (€29,265, n = 17). National Health Service costs accounted for approximately 38% and social services for 34% of the direct costs of care. Drug expenditure accounted for 24% of overall costs in the <65 years age group and 10% in patients aged >85 years. A move from home to residential care was associated with an approximately 500% cost increase. In conclusion, PD imposes significant direct costs on public services and on individuals. These costs should be taken into account when allocating public funds. © 2003 Movement Disorder Society

[1]  J. Reid,et al.  The symptoms of patients treated for Parkinson's disease. , 1985, Clinical neuropharmacology.

[2]  R. Fitzpatrick,et al.  The development and validation of a short measure of functioning and well being for individuals with Parkinson's disease , 1995, Quality of Life Research.

[3]  D P Salmon,et al.  The Mini-Mental State Examination in the early diagnosis of Alzheimer's disease. , 1990, Archives of neurology.

[4]  R. Dodel,et al.  [Cost of illness in Parkinson disease. A retrospective 3-month analysis of direct costs]. , 1997, Der Nervenarzt.

[5]  A. Gray,et al.  Estimating the relationship between disease progression and cost of care in dementia , 2002, British Journal of Psychiatry.

[6]  A. Kasuya.  EuroQol--a new facility for the measurement of health-related quality of life. , 1990, Health policy.

[7]  D. Wade,et al.  The Barthel ADL Index: a standard measure of physical disability? , 1988, International disability studies.

[8]  J. Dartigues,et al.  Prevalence of parkinsonism and Parkinson's disease in Europe: the EUROPARKINSON Collaborative Study. European Community Concerted Action on the Epidemiology of Parkinson's disease. , 1997, Journal of neurology, neurosurgery, and psychiatry.

[9]  S G Thompson,et al.  Analysis and interpretation of cost data in randomised controlled trials: review of published studies , 1998, BMJ.

[10]  D. Quinton,et al.  Unit Costs of Health and Social Care 2004 , 2004 .

[11]  G. Small,et al.  The Impact of Symptom Severity on the Cost of Alzheimer's Disease , 2002, Journal of the American Geriatrics Society.

[12]  S. Campbell,et al.  Acute hospital admissions from nursing homes: some may be avoidable , 2001, Postgraduate medical journal.

[13]  M. Hoehn,et al.  Parkinsonism , 1967, Neurology.

[14]  A. Williams.  EuroQol : a new facility for the measurement of health-related quality of life , 1990 .

[15]  M. Carpenter,et al.  Functional relationships between the red nucleus and the brachium conjunctivum; physiologic study of lesions of the red nucleus in monkeys with degenerated superior cerebellar brachia. , 1957, Neurology.

[16]  K Whetten-Goldstein,et al.  The Burden of Parkinson's Disease on Society, Family, and the Individual , 1997, Journal of the American Geriatrics Society.

[17]  R B Wallace,et al.  The health burdens of Parkinson's disease , 1998, Movement disorders : official journal of the Movement Disorder Society.

[18]  B. C. Robinson.  Validation of a Caregiver Strain Index. , 1983, Journal of gerontology.

[19]  W. Scholz,et al.  Krankheitskosten der Parkinson-Erkrankung Eine retrospektive dreimonatige Analyse der direkten Kosten , 1997, Der Nervenarzt.

[20]  F. Salaffi,et al.  A multicenter cost-of-illness study on rheumatoid arthritis in Italy. , 2002, Clinical and experimental rheumatology.